InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Amin Naseem. Director active across 2 companies, notably Bellerophon Therapeutics, Inc.. Aggregated, 6 filings have been recorded. History available since 31 December 2021. The latest transaction was disclosed on 12 February 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Amin Naseem
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
22,000 股@ US$21.00100.0% 占其流量Ordinary SharesSEC:0001104659-26-014438:0
11,000 股0Ordinary SharesSEC:0001104659-25-072682:0
11,000 股0Ordinary SharesSEC:0001104659-24-084933:0
47,578 股0Common StockSEC:0001104659-23-069913:0
84,000 股0Common StockSEC:0001415889-23-002555:0
39,032 股0Common StockSEC:0001415889-22-000186:0
6 条申报中的 6 条
About Amin Naseem
Amin Naseem is a declarant linked to Avadel Pharmaceuticals PLC, where he is a Director, and to Bellerophon Therapeutics, Inc., where he is also a Director. The record shows 6 filings in total, and across the 6 most recent filings held, the period runs from 2022-01-04 to 2026-02-12, with sales of EUR 389018 and no purchases; the most common transaction nature is Attribution.
